Qiang Xu is a Partner at Decheng Capital since its inception, serving on multiple boards. He has over 14 years of experience in biotechnology and agricultural biotechnology.
At firms with a similar stage, sector and check size.

One email when Qiang's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQiang Xu is a Partner at Decheng Capital since its inception, serving on multiple boards. He has over 14 years of experience in biotechnology and agricultural biotechnology.
Decheng Capital has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Decheng Capital backed works best.
scientist at Bayer; member of the Alzheimers Disease Discovery Program at Scios; director at Pan Pacific Pharmaceuticals; Vice President of Research at Osel; Scios.
Last updated 2026-10-15. Is this you? Ask for a correction.